Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2000
12/07/2000WO2000072838A1 New use of compounds as antibacterial agents
12/07/2000WO2000072832A2 Novel use of 1-[4-(cyanoindol-3yl)butyl]-4-(carbamoyl-benzofuran-5yl)-piperazine and its physiologically acceptable salts
12/07/2000WO2000035443A9 Method and composition for the maintenance and restitution of gut integrity
12/07/2000DE19919585A1 Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen Use of Phyllanthus for the treatment of oxidative stress and other symptoms
12/07/2000CA2694866A1 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
12/07/2000CA2414094A1 Pharmaceutical preparations of bioactive substances extracted from natural sources
12/07/2000CA2375855A1 Modulation of gene expression in gastrointestinal inflammation
12/07/2000CA2375827A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders
12/07/2000CA2375683A1 Il-8 receptor antagonists
12/07/2000CA2375147A1 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
12/07/2000CA2375104A1 Prevention and treatment of amyloidogenic disease
12/07/2000CA2375047A1 Dna encoding snorf33 receptor
12/07/2000CA2374376A1 Lipid metabolism transcription factor
12/07/2000CA2374295A1 Il-8 receptor antagonists
12/07/2000CA2374222A1 Cytoskeleton-associated proteins
12/07/2000CA2374133A1 Structural models for cytoplasmic domains of transmembrane receptors
12/07/2000CA2372250A1 Fimbrial proteins
12/07/2000CA2372249A1 Chemokine receptor ccr3 antagonists
12/07/2000CA2372246A1 Human tumor necrosis factor receptor tr10
12/07/2000CA2372236A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo¬2,2,2|oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists
12/07/2000CA2372234A1 Oxazaheterocycles as protease inhibitors
12/07/2000CA2371995A1 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
12/07/2000CA2371089A1 3-heteroarylalkyl substituted gaba analogs
12/07/2000CA2370598A1 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors
12/07/2000CA2336262A1 Sorting nexins
12/06/2000EP1057826A1 Substituted dimeric carboxamide derivatives, method for preparing them, and pharmaceutical compositions containing them
12/06/2000EP1056877A1 Self-regulated apoptosis of inflammatory cells by gene therapy
12/06/2000EP1056754A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone
12/06/2000EP1056733A1 Histamine h3 receptor ligands
12/06/2000EP1056731A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone
12/06/2000EP1056730A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone
12/06/2000EP1056464A1 L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
12/06/2000EP1056457A1 S-lansoprazole compositions and methods
12/06/2000EP1056455A1 Epimorphian compound and its use
12/06/2000EP1056451A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
12/06/2000EP1056449A2 20-hete antagonists and agonists
12/06/2000EP1056442A1 Antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa
12/06/2000EP1024701A4 Methods and compositions for the treatment of autoimmune disease using heat shock proteins
12/06/2000CN1276009A Electric coated microgranules for stabilizing lactic acid bacteria
12/06/2000CN1275981A Novel pharmaceutically active compounds, their preparation and use as ECE-inhibitors
12/06/2000CN1275908A Preparation of directly mouldable tabletting auxiliary
12/06/2000CN1275906A Plaque-inhibiting oral compositions
12/06/2000CN1275392A Preparation for treating child virus diarrhea
12/06/2000CN1275391A Oral proprietary medicine for normalizing secretion and removing urinary calcultus
12/06/2000CN1275387A Oral liquor and preparation process thereof
12/06/2000CN1275381A Medicine for treating hepatitis and productive process thereof
12/06/2000CN1275376A Hydroxy diphenyl ether compound
12/06/2000CN1275346A Method and equipment for destructive distillation of haw kernel to extract juice
12/06/2000CN1059210C Process for preparation of 6-heterocyclic-4-amino-1,3,4,5-tetrahydrbenz [cd] indoles and acid additive salt used as medicine
12/06/2000CN1059127C Process for preparation of Shuganmei medicine for treating liver disease
12/06/2000CN1059116C Traditional Chinese medicine for treating hepatitis B
12/06/2000CN1059109C Traditional Chinese medicine for treating ascites ue to cirrhosis
12/06/2000CN1059104C Traditional Chinese medicinal capsule for treating hepatitis B
12/06/2000CN1059101C Pill made of eight Chinese medicinal herbs for treating enteritis
12/06/2000CN1059099C Traditional Chinese medicine pill for treating gastrosia
12/06/2000CN1059098C Medicine for curing tooth-ache and preparation process thereof
12/05/2000US6156878 Amino acid sequences; for antibodies, immunosuppressants, immunomodulators, immunotoxins, and diagnosis of related disorders
12/05/2000US6156770 Antiviral agents, bactericides, antitumor agents and antihistamines
12/05/2000US6156757 1,2,3,4-tetrahydro-benzofuro[3,2-C]pyridine derivatives
12/05/2000US6156752 Optically active 1,4-dihydropyridine compounds as bradykinin antagonists
12/05/2000US6156747 Psychological, gastrointestinal, cardiovascular disorders
12/05/2000US6156737 Therapy for hepatitis b
12/05/2000US6156535 Nucleotide sequences coding inhibitor of apoptosis protein; for diagnosing a cell proliferation defect
12/05/2000US6156523 Serine/threonine protein kinases
12/05/2000US6156293 Moistening preparation
11/2000
11/30/2000WO2000071728A1 Recombinant bacterial phytases and uses thereof
11/30/2000WO2000071585A1 Human antibodies to staphylococcus aureus
11/30/2000WO2000071584A1 Seven transmembrane receptor genes
11/30/2000WO2000071577A1 Meth1 and meth2 polynucleotides and polypeptides
11/30/2000WO2000071560A1 Methods of modulating activity of prokaryotic ribosomes
11/30/2000WO2000071549A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000WO2000071548A1 Substituted imidazothiazoles as antidepressant agents
11/30/2000WO2000071538A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
11/30/2000WO2000071537A1 New pharmaceutically active compounds
11/30/2000WO2000071535A1 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE
11/30/2000WO2000071517A1 Phenoxypropylamine compounds
11/30/2000WO2000071514A1 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS
11/30/2000WO2000071502A1 Hydrazide derivatives
11/30/2000WO2000071164A1 Inhibition of gastric acid production and/or secretion
11/30/2000WO2000071151A1 Liver function controlling agents
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071140A2 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000WO2000071138A2 Oral administration of lactobacillus for the maintenance of health in women
11/30/2000WO2000071134A1 Isophosphoramide mustard analogs and use thereof
11/30/2000WO2000071122A1 Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
11/30/2000WO2000071121A1 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations
11/30/2000WO2000071118A1 Phospholipase a2-specific inhibiting compounds
11/30/2000WO2000071103A2 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
11/30/2000WO2000071101A2 Methods and compounds for inhibiting amyloid deposits
11/30/2000WO2000070972A1 New composition
11/30/2000WO2000047611A3 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
11/30/2000WO2000043413A3 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
11/30/2000WO2000042172A3 Human homologues of proteins regulated by circadian rhythms
11/30/2000WO2000040241A3 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
11/30/2000WO2000037096A3 Treatment of hepatitis c virus infections with interleukin-10
11/30/2000WO2000035434A3 Compositions and methods for the treatment of anorectal disorders
11/30/2000WO2000028019A3 Antisense oligomer
11/30/2000WO2000026380A9 Rotavirus subunit vaccine
11/30/2000DE19923961A1 Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
11/30/2000DE10016771A1 Nutritional supplements containing flavonoid and catechin derivatives
1 ... 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 ... 1258